Authors' reply to commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Affiliations

¹ Departments of Medicine and Epidemiology, McGill University, Montreal, QC, Canada.
² University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada.

Comment

James M Brophy et al. Int J Epidemiol. 2018.

. 2018 Apr 1;47(2):674-675.

doi: 10.1093/ije/dyy050.

¹ Departments of Medicine and Epidemiology, McGill University, Montreal, QC, Canada.
² University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada.

No abstract available

Comment in

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.
Henry D, Stehlik P, Rosella L. Henry D, et al. Int J Epidemiol. 2018 Apr 1;47(2):675-676. doi: 10.1093/ije/dyy051. Int J Epidemiol. 2018. PMID: 29618002 No abstract available.

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.
Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. Bally M, et al. BMJ. 2017 May 9;357:j1909. doi: 10.1136/bmj.j1909. BMJ. 2017. PMID: 28487435 Free PMC article.
Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.
Stehlik P, Rosella L, Henry D. Stehlik P, et al. Int J Epidemiol. 2018 Apr 1;47(2):362-367. doi: 10.1093/ije/dyx284. Int J Epidemiol. 2018. PMID: 29390133 No abstract available.